Mortgage and refinance interest rates today, July 27, 2025: Rates are expected to stay high through 2025
Though rates are decreasing, 30-year fixed mortgage rates have only gone down 0.04%, while 15-year rates fell a mere 0.02% according to Freddie Mac data. If you are looking to buy a house, it makes the most sense to lock in a mortgage when it fits your financial situation, rather than waiting to see if on interest rates get lower in the future.
Dig deeper: 2025 housing market — Is it a good time to buy a house?
Current mortgage rates
Here are the current mortgage rates, according to the latest Zillow data:
30-year fixed: 6.68%
20-year fixed: 6.52%
15-year fixed: 5.91%
5/1 ARM: 7.26%
7/1 ARM: 7.25%
30-year VA: 6.29%
15-year VA: 5.64%
5/1 VA: 6.15%
Remember, these are the national averages and rounded to the nearest hundredth.
Learn more: 8 strategies for getting the lowest mortgage rates
Current mortgage refinance rates
These are today's mortgage refinance rates, according to the latest Zillow data:
30-year fixed: 6.79%
20-year fixed: 6.31%
15-year fixed: 5.91%
5/1 ARM: 7.37%
7/1 ARM: 7.15%
30-year VA: 6.26%
15-year VA: 6.11%
5/1 VA: 5.86%
Again, the numbers provided are national averages rounded to the nearest hundredth. Mortgage refinance rates are often higher than rates when you buy a house, although that's not always the case.
Read more: Is now a good time to refinance your mortgage?
Refinance interest rates
Up Next
Up Next
Monthly mortgage payment calculator
Use the mortgage calculator below to see how various mortgage terms and interest rates will impact your monthly payments.
Our free mortgage calculator also considers factors like property taxes and homeowners insurance when determining your estimated monthly mortgage payment. This gives you a more realistic idea of your total monthly payment than if you just looked at mortgage principal and interest.
30-year vs. 15-year fixed mortgage rates
The average 30-year mortgage rate today is 6.68%. A 30-year term is the most popular type of mortgage because by spreading out your payments over 360 months, your monthly payment is lower than with a shorter-term loan.
The average 15-year mortgage rate is 5.91% today. When deciding between a 15-year and a 30-year mortgage, consider your short-term versus long-term goals.
A 15-year mortgage comes with a lower interest rate than a 30-year term. This is great in the long run because you'll pay off your loan 15 years sooner, and that's 15 fewer years for interest to accumulate. But the trade-off is that your monthly payment will be higher as you pay off the same amount in half the time.
Let's say you get a $300,000 mortgage. With a 30-year term and a 6.68% rate, your monthly payment toward the principal and interest would be about $1,932, and you'd pay $395,468 in interest over the life of your loan — on top of that original $300,000.
If you get that same $300,000 mortgage with a 15-year term and a 5.91% rate, your monthly payment would jump to $2,846. But you'd only pay $153,061 in interest over the years.
Fixed-rate vs. adjustable-rate mortgages
With a fixed-rate mortgage, your rate is locked in for the entire life of your loan. You will get a new rate if you refinance your mortgage, though.
An adjustable-rate mortgage keeps your rate the same for a predetermined period of time. Then, the rate will go up or down depending on several factors, such as the economy and the maximum amount your rate can change according to your contract. For example, with a 7/1 ARM, your rate would be locked in for the first seven years, then change every year for the remaining 23 years of your term.
Adjustable rates typically start lower than fixed rates, but once the initial rate-lock period ends, it's possible your rate will go up. Lately, though, some fixed rates have been starting lower than adjustable rates. Talk to your lender about its rates before choosing one or the other.
Dig deeper: Fixed-rate vs. adjustable-rate mortgages
How to get a low mortgage rate
Mortgage lenders typically give the lowest mortgage rates to people with higher down payments, great or excellent credit scores, and low debt-to-income ratios. So, if you want a lower rate, try saving more, improving your credit score, or paying down some debt before you start shopping for homes.
Waiting for rates to drop probably isn't the best method to get the lowest mortgage rate right now. If you're ready to buy, focusing on your personal finances is probably the best way to lower your rate.
How to choose a mortgage lender
To find the best mortgage lender for your situation, apply for mortgage preapproval with three or four companies. Just be sure to apply to all of them within a short time frame — doing so will give you the most accurate comparisons and have less of an impact on your credit score.
When choosing a lender, don't just compare interest rates. Look at the mortgage annual percentage rate (APR) — this factors in the interest rate, any discount points, and fees. The APR, which is also expressed as a percentage, reflects the true annual cost of borrowing money. This is probably the most important number to look at when comparing mortgage lenders.
Learn more: Best mortgage lenders for first-time home buyers
Current mortgage rates: FAQs
What is a mortgage interest rate at right now?
According to Zillow, the national average 30-year mortgage rate for purchasing a home is 6.68%, and the average 15-year mortgage rate is 5.91%. But these are national averages, so the average in your area could be different. Averages are typically higher in expensive parts of the U.S. and lower in less expensive areas.
What's a good mortgage rate right now?
The average 30-year fixed mortgage rate is 6.68% right now, according to Zillow. However, you might get an even better rate with an excellent credit score, sizable down payment, and low debt-to-income ratio (DTI).
Are mortgage rates expected to drop?
Mortgage rates aren't expected to drop drastically in the near future, though they may inch down now and then.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Arm Q1 2026 Earnings Preview: Royalty Ramp in Focus
Arm will release fiscal first-quarter results after the bell on July 30, 2025. Consensus targets call for 12% revenue growth but a 13% drop in EPS versus Q1 2025. Shares are up 32% YTD, a move powered by AI and IoT demand. Royalty backlog and AI demand are the key watch-points. Remaining performance obligations were $2.23 billion at the end of Q4 FY25, down 10% YoY as prior deals converted to revenue. Management has called the drop timing-related and says growing Armv9 use in cloud and automotive will lift royalties through FY 2026. An update on large AI-accelerator licenses now in negotiation could refill RPO and restore confidence in the full-year sales range. Investors also want proof that a richer royalty mix can keep operating margin in the mid-40s while R&D rises to defend IP. Arm trades at 91 forward P/E and 35 forward P/S. A clean beat with upbeat AI and IoT commentary could keep that premium intact, but a renewed guide cut or slower royalty run-rate might cap any post-print upside. This article first appeared on GuruFocus.


Business Wire
2 hours ago
- Business Wire
Renesas Introduces 64-bit RZ/G3E MPU for High-Performance HMI Systems Requiring AI Acceleration and Edge Computing
TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today announced the launch of its new 64-bit RZ/G3E microprocessor (MPU), a general-purpose device optimized for high-performance Human Machine Interface (HMI) applications. Combining a quad-core Arm® Cortex®-A55 running at up to 1.8GHz with a Neural Processing Unit (NPU), the RZ/G3E brings high-performance edge computing with AI inference for faster, more efficient local processing. With Full HD graphics support and high-speed connectivity, the MPU targets HMI systems for industrial and consumer segments including factory equipment, medical monitors, retail terminals and building automation. 'The RZ/G3E builds on the proven performance of the RZ/G series with the addition of an NPU to support AI processing,' said Daryl Khoo, Vice President of Embedded Processing at Renesas. High-Performance Edge Computing and HMI Capabilities At the heart of the RZ/G3E is a quad-core Arm Cortex-A55, a Cortex-M33 core, and the Ethos™-U55 NPU for AI tasks. This architecture efficiently runs AI applications such as image classification, object recognition, voice recognition and anomaly detection while minimizing CPU load. Designed for HMI applications, it delivers smooth Full HD (1920x1080) video at 60fps on two independent displays, with output interfaces including LVDS (dual-link), MIPI-DSI, and parallel RGB. A MIPI-CSI camera interface is also available for video input and sensing applications. 'The RZ/G3E builds on the proven performance of the RZ/G series with the addition of an NPU to support AI processing,' said Daryl Khoo, Vice President of Embedded Processing at Renesas. 'By using the same Ethos-U55 NPU as our recently announced RA8P1 microcontroller, we're expanding our AI embedded processor portfolio and offering a scalable path forward for AI development. These advancements address the demands of next-generation HMI applications across vision, voice and real-time analytics with powerful AI capabilities.' The RZ/G3E is equipped with a range of high-speed communication interfaces essential for edge devices. These include PCI Express 3.0 (2 lanes) for up to 8Gbps, USB 3.2 Gen2 for fast 10Gbps data transfer, and dual-channel Gigabit Ethernet for seamless connectivity with cloud services, storage, and 5G modules. Low-Power Standby with Fast Linux Resume Starting with the third-generation RZ/G3S, the RZ/G series includes advanced power management features to significantly reduce standby power. The RZ/G3E maintains sub-CPU operation and peripheral functions while achieving low power consumption around 50mW and around 1mW in deep standby mode. It supports DDR self-refresh mode to retain memory data, enabling quick wake-up from deep standby for running Linux applications. Comprehensive Linux Software Support Renesas continues to offer the Verified Linux Package (VLP) based on the reliable Civil Infrastructure Platform, with over 10 years of maintenance support. For users requiring the latest versions, Renesas provides Linux BSP Plus, including support for the latest LTS Linux kernel and Yocto. Ubuntu by Canonical and Debian open-source OS are also available for server or desktop Linux environments. Key Features of RZ/G3E CPU: Quad-core Cortex-A55 (up to 1.8GHz), Cortex-M33 NPU: Ethos-U55 (512 GOPS) HMI: Dual Full HD output, MIPI-DSI / Dual-link LVDS / Parallel RGB, 3D graphics, H.264/H.265 codec Memory Interface: 32-bit LPDDR4/LPDDR4X with ECC Connectivity for 5G Communication: PCIe 3.0 (2 lanes), USB 3.2 Gen2, USB 2.0 x2, Gigabit Ethernet x2, CAN-FD Operating Temperature: -40°C to 125°C Package Options: 15mm square 529-pin FCBGA, 21mm square 625-pin FCBGA Product Longevity: 15-year supply under Product Longevity Program (PLP) System-on-Module Solutions from Renesas and Ecosystem Partners Renesas has also introduced system-on-module (SoM) solutions featuring the RZ/G3E. A broad range of SoM solutions will be available from Renesas' ecosystem partners such as a SMARC module from Tria, an OSM (Size-M) from ARIES Embedded, and an OSM (Size-L) from MXT. Winning Combinations Renesas combined the RZ/G3E with other compatible devices to develop Full HD Dual-Display HMI Platform and Digital Otoscope solutions. These Winning Combinations are technically vetted system architectures from mutually compatible devices that work together seamlessly to bring an optimized, low-risk design for faster time to market. Renesas offers more than 400 Winning Combinations with a wide range of products from the Renesas portfolio to enable customers to speed up the design process and bring their products to market more quickly. They can be found at Availability The RZ/G3E is available today, along with the Evaluation Board Kit. The kit includes a SMARC v2.1.1 module board and a carrier board. More information about Renesas RZ/G3E is available at: About Renesas Electronics Corporation Renesas Electronics Corporation (TSE: 6723) empowers a safer, smarter and more sustainable future where technology helps make our lives easier. A leading global provider of microcontrollers, Renesas combines our expertise in embedded processing, analog, power and connectivity to deliver complete semiconductor solutions. These Winning Combinations accelerate time to market for automotive, industrial, infrastructure and IoT applications, enabling billions of connected, intelligent devices that enhance the way people work and live. Learn more at Follow us on LinkedIn, Facebook, X, YouTube, and Instagram. (Remarks) All names of products or services mentioned in this press release are trademarks or registered trademarks of their respective owners.
Yahoo
2 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@